Antipsychotic Medications
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
Schizophrenia was invariably accompanied by positive symptoms, such as
disruptive, peculiar, and potentially hazardous behavior, until the mid-20th
century. Schizophrenics were subsequently confined to asylums in order to
safeguard them from themselves and society. A substance known as
chlorpromazine (Thorazine) was discovered in the 1950s that had the potential
to alleviate a significant number of the positive symptoms of schizophrenia.
Chlorpromazine was the initial of numerous antipsychotic medications.
Neuroleptics, which are antipsychotic medicines, are medications that alleviate
the symptoms of schizophrenia and other psychotic disorders. Thorazine,
Haldol, Clozaril, Risperdal, and Zyprexa are among the numerous
antipsychotics that are currently available. Some of these medications address
the cognitive, negative, and positive symptoms of schizophrenia.
The single greatest advance in psychiatric care has been characterized as the
discovery of chlorpromazine and its use in clinics, as it has significantly
enhanced the prognosis of patients in psychiatric hospitals worldwide.
Antipsychotic medications have enabled hundreds of thousands of individuals
to transition from asylums to individual households or community mental health
centers, and in numerous instances, to lead nearly normal lives.
Antipsychotics ameliorate negative symptoms by influencing levels of
serotonin, and they reduce the positive symptoms of schizophrenia by reducing
the transmission of dopamine at the synapses in the limbic system (Marangell,
Silver, Goff, & Yudofsky, 2003). Although antipsychotics are effective, they
can also cause negative side effects such as vertigo, restlessness, muscle
spasms, and blurred vision. Furthermore, their prolonged use can result in
persistent neurological damage, a condition known as tardive dyskinesia, which
typically manifests as uncontrollable muscle movements in the oral region
(National Institute of Mental Health, 2008). Newer antipsychotics address a
greater number of symptoms with fewer adverse effects than their predecessors
(Casey, 1996).
